Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)

Clinical trial NCT00908921 · COMPLETED

Trial details

NCT number: NCT00908921
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2009-04-01
Primary completion: 2010-09-01
Enrollment: 391

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.